Registered entities
Acclarent, Inc
Reg. No. 201772549United States
Innovation
342 patent families (217 granted) — focus: Human necessities, Physics & computing, Electricity & electronics, Textiles & paper; filing pace slowing. Cited 178,043 times.
| Year | Filings |
|---|---|
| 2015 | 57 |
| 2016 | 71 |
| 2017 | 74 |
| 2018 | 64 |
| 2019 | 108 |
| 2020 | 86 |
| 2021 | 82 |
| 2022 | 48 |
| 2023 | 58 |
| 2024 | 73 |
| 2025 | 48 |
| 2026 | 8 |
Social engagement
Social engagement: 13.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Meritech; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 2 | 33% |
Recent activity
2 Jul 2026
Product launch
1 Jul 2026
Product launch
RELIEVA SPINPLUS® Balloon Sinuplasty System
30 Jun 2026
Product launch
ACCLARENT AERA® Eustachian Tube Balloon Dilation System
